Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: MCR011
MIFTS: 47

Microinvasive Gastric Cancer

Categories: Cancer diseases, Gastrointestinal diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Microinvasive Gastric Cancer

About this section

MalaCards integrated aliases for Microinvasive Gastric Cancer:

Name: Microinvasive Gastric Cancer 12 15
Early Gastric Cancer 12 56 15 74
Surface Gastric Cancer 12

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Gastrointestinal diseases
See all MalaCards categories (disease lists)


External Ids:

Disease Ontology 12 DOID:10541
NCIt 51 C27131
UMLS 74 C0349530
Sources

Summaries for Microinvasive Gastric Cancer

About this section
MalaCards based summary : Microinvasive Gastric Cancer, also known as early gastric cancer, is related to gastric cancer and tubular adenocarcinoma, and has symptoms including abdominal pain and dyspepsia. An important gene associated with Microinvasive Gastric Cancer is TDRG1 (Testis Development Related 1), and among its related pathways/superpathways are Pathways in cancer and Gastric cancer. The drugs Rabeprazole and Clopidogrel have been mentioned in the context of this disorder. Affiliated tissues include lymph node, liver and bone, and related phenotypes are digestive/alimentary and neoplasm

Sources

Related Diseases for Microinvasive Gastric Cancer

About this section

Diseases related to Microinvasive Gastric Cancer via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 212)
# Related Disease Score Top Affiliating Genes
1 gastric cancer 31.0 CDH1 CDX2 MLH1 TDRG1 TP53 VEGFC
2 tubular adenocarcinoma 30.0 CDH1 CDX2
3 peptic esophagitis 29.9 ATP12A ATP4A
4 hernia, hiatus 29.9 ATP12A ATP4A
5 familial adenomatous polyposis 29.9 CDH1 MLH1 TP53
6 pseudomyxoma peritonei 29.7 CDX2 TP53
7 esophageal varix 29.6 ATP12A ATP4A
8 cholangiocarcinoma 29.3 CDH1 CDX2 TP53 VEGFC
9 esophageal cancer 29.3 BCYRN1 CDH1 CDX2 TP53 VEGFC XIST
10 gastric lymphoma 29.3 ATP12A ATP4A TP53
11 gastric adenocarcinoma 29.2 CDH1 CDX2 MLH1 TP53 VEGFC
12 gastric diffuse adenocarcinoma 10.3 CDH1 CDX2
13 adenosquamous colon carcinoma 10.3 CDX2 MLH1
14 adenoma 10.3
15 gastric signet ring cell adenocarcinoma 10.3 CDH1 CDX2
16 signet ring cell adenocarcinoma 10.3 CDH1 CDX2
17 helicobacter pylori infection 10.3
18 adenocarcinoma 10.3
19 gastritis 10.3
20 degos 'en cocarde' erythrokeratoderma 10.3
21 cerebral convexity meningioma 10.2 CDH1 TP53
22 sarcomatoid renal cell carcinoma 10.2 CDH1 TP53
23 nasal cavity adenocarcinoma 10.2 CDX2 TP53
24 lymphoma 10.2
25 anal squamous cell carcinoma 10.2 MLH1 TP53
26 biliary papillomatosis 10.2 CDX2 TP53
27 endocervical adenocarcinoma 10.2 CDX2 TP53
28 vulvar disease 10.1 SCN10A TP53
29 cecum adenocarcinoma 10.1 CDX2 MLH1
30 appendix cancer 10.1 CDX2 TP53
31 liver cirrhosis 10.1
32 situs inversus 10.1
33 cystic teratoma 10.1 CDX2 TP53
34 laryngeal squamous cell carcinoma 10.1 CDH1 RRP1B TP53
35 richter's syndrome 10.1 MLH1 TP53
36 dextrocardia with situs inversus 10.1
37 cervical squamous cell carcinoma 10.1 CDH1 TP53 XIST
38 fungal esophagitis 10.1 ATP12A ATP4A
39 diclofenac allergy 10.1 ATP12A ATP4A
40 gastroduodenal crohn's disease 10.1 ATP12A ATP4A
41 neonatal candidiasis 10.1 ATP12A ATP4A
42 photoallergic dermatitis 10.1 ATP12A ATP4A
43 hidradenocarcinoma 10.1 CDX2 TP53
44 squamous papillomatosis 10.1 ATP12A ATP4A
45 penile disease 10.1 SCN10A TP53
46 toxic megacolon 10.1 ATP12A ATP4A
47 aspiration pneumonitis 10.1 ATP12A ATP4A
48 gastrointestinal neuroendocrine benign tumor 10.1 ATP12A ATP4A
49 gastric antral vascular ectasia 10.1 ATP12A ATP4A
50 granulomatous gastritis 10.1 ATP12A ATP4A

Graphical network of the top 20 diseases related to Microinvasive Gastric Cancer:



Diseases related to Microinvasive Gastric Cancer
Sources

Symptoms & Phenotypes for Microinvasive Gastric Cancer

About this section

UMLS symptoms related to Microinvasive Gastric Cancer:


abdominal pain, dyspepsia

MGI Mouse Phenotypes related to Microinvasive Gastric Cancer:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.43 ATP12A ATP4A CDH1 CDX2 MLH1 TP53
2 neoplasm MP:0002006 9.02 ATP4A CDH1 CDX2 MLH1 TP53
Sources

Drugs & Therapeutics for Microinvasive Gastric Cancer

About this section

Drugs for Microinvasive Gastric Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 123)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Rabeprazole Approved, Investigational Phase 4,Phase 3 117976-89-3 5029
2
Clopidogrel Approved Phase 4 120202-66-6, 113665-84-2 60606
3
Pantoprazole Approved Phase 4,Not Applicable 102625-70-7 4679
4
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
5
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4 7487-88-9 24083
6
Calcium Approved, Nutraceutical Phase 4 7440-70-2 271
7
Ecabet Investigational Phase 4 33159-27-2, 86408-72-2 65781
8 Anti-Ulcer Agents Phase 4,Phase 3,Not Applicable
9 Antacids Phase 4,Phase 3,Not Applicable
10 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable
11 Proton Pump Inhibitors Phase 4,Phase 3,Not Applicable
12 Antirheumatic Agents Phase 4
13 Analgesics, Non-Narcotic Phase 4,Not Applicable
14 Platelet Aggregation Inhibitors Phase 4
15 Purinergic P2Y Receptor Antagonists Phase 4
16 Purinergic P2 Receptor Antagonists Phase 4
17 Analgesics Phase 4,Phase 3,Phase 2,Not Applicable
18 Cyclooxygenase Inhibitors Phase 4
19 Anti-Inflammatory Agents, Non-Steroidal Phase 4
20 Antipyretics Phase 4
21 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Not Applicable
22 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Not Applicable
23 Anti-Inflammatory Agents Phase 4,Not Applicable
24 Fibrinolytic Agents Phase 4
25 HIV Protease Inhibitors Phase 4,Not Applicable
26
protease inhibitors Phase 4,Not Applicable
27 Anti-Infective Agents Phase 4,Phase 3
28 Protective Agents Phase 4,Not Applicable
29 Hormones Phase 4,Not Applicable
30 Anesthetics Phase 4,Phase 3,Not Applicable
31 Central Nervous System Depressants Phase 4,Phase 3,Not Applicable
32 Anticonvulsants Phase 4
33 Calcium, Dietary Phase 4
34 Anti-Arrhythmia Agents Phase 4
35 calcium channel blockers Phase 4
36 Tocolytic Agents Phase 4
37
Meperidine Approved Phase 3 57-42-1 4058
38
Midazolam Approved, Illicit Phase 3,Not Applicable 59467-70-8 4192
39
Menthol Approved Phase 3 2216-51-5 16666
40
Clarithromycin Approved Phase 3 81103-11-9 84029
41
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613
42
Omeprazole Approved, Investigational, Vet_approved Phase 3 73590-58-6 4594
43 Analgesics, Opioid Phase 3,Not Applicable
44 Anesthetics, Intravenous Phase 3,Not Applicable
45 Narcotics Phase 3,Not Applicable
46 Psychotropic Drugs Phase 3,Not Applicable
47 Anti-Anxiety Agents Phase 3,Not Applicable
48 GABA Modulators Phase 3,Not Applicable
49 Adjuvants, Anesthesia Phase 3,Not Applicable
50 Hypnotics and Sedatives Phase 3,Not Applicable

Interventional clinical trials:

(show top 50) (show all 92)
# Name Status NCT ID Phase Drugs
1 Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. Unknown status NCT02638584 Phase 4 Ilaprazole;Rabeprazole
2 Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? Unknown status NCT01621451 Phase 4 aspirin and/or clopidogrel;aspirin and/or clopidogrel
3 Efficacy of Ecabet Sodium and Proton Pump Inhibitor Combination Therapy in the Treatment of Iatrogenic Ulcer After Endoscopic Submucosal Dissection Unknown status NCT01308177 Phase 4 Ecabet
4 The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study Completed NCT02235246 Phase 4 Magnesium Sulfate;Normal saline
5 Efficacy of Bispectral Index Monitoring for Midazolam and Meperidine Induced Sedation During Endoscopic Submucosal Dissection Unknown status NCT01157598 Phase 3
6 Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients Unknown status NCT02246153 Phase 3
7 Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01) Unknown status NCT01609309 Phase 3
8 Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301) Completed NCT00546468 Phase 3
9 Phase III Study of NPO-11 in Patients Undergoing Therapeutic Upper Gastrointestinal Endoscopy Completed NCT01411176 Phase 3 Menthol;Placebo
10 Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases Completed NCT02219529 Phase 3
11 Comparison of Laparoscopic Pylorus Preserving Gastrectomy Versus Laparoscopic Distal Gastrectomy Recruiting NCT02595086 Phase 3
12 A Comparison Laparoscopic With Open Gastric Cancer Surgery for Locally Advanced Gastric Cancer Recruiting NCT02748551 Phase 3
13 Multicenter Phase III Trial of Laparoscopic Sentinel Node Biopsy Active, not recruiting NCT01804998 Phase 3
14 Effects of H. Pylori Eradication on the Gastric Preneoplastic Lesion and Neoplasm After ESD Active, not recruiting NCT02407119 Phase 3 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin;Placebo, Omeprazole or Rabeprazole, Clarithromycin
15 Uncut Roux-en-Y Gastrojejunostomy for Early Gastric Cancer Patients Unknown status NCT02644148 Phase 2
16 Phase II Study for Robot Assisted Distal Gastrectomy Unknown status NCT01504997 Phase 2
17 The Advantages and Disadvantages Between Uncut Roux-en-Y Reconstruction and Billroth II Reconstruction After Laparoscopy-assisted Distal Gastrectomy for Gastric Unknown status NCT02694081 Phase 2
18 The Safety and Feasibility of Reduced Port Robotic Distal Gastrectomy Using Single-site for Surgical Treatment of Early Gastric Cancer Completed NCT02347956 Phase 1, Phase 2
19 Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Gastrectomy Completed NCT02522598 Phase 2 VVZ-149 injections;Placebo
20 Laparoscopic Gastrectomy for Advanced Gastric Cancer Completed NCT01441336 Phase 2
21 Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2) Recruiting NCT03837301 Phase 2
22 Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma Recruiting NCT03814759 Phase 2 TS-1 + cisplatin
23 Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients Recruiting NCT03564834 Phase 2
24 The Feasible Research of Infrared Endoscope to Diagnose Early Gastric Cancer Unknown status NCT02710838 Not Applicable
25 Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer Unknown status NCT01659632
26 the Train the Trainer (TTT) Plan, to Improve the Young Endoscopist's Ability to Find the Early Gastric Cancer Unknown status NCT02385578 Not Applicable
27 Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer Unknown status NCT01832246
28 Efficacy and Safety Study of Endoscopic Submucosal Dissection for Early Gastric Cancer Unknown status NCT01132469 Not Applicable
29 Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection Unknown status NCT02037399 Not Applicable intravenous dexamethasone;intravenous normal saline
30 Difference in H. Pylori Infection Rate of EGC Patients Before and After Endoscopic Resection Unknown status NCT02090062
31 Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer Unknown status NCT01774266
32 The Predictive Scores for Gastric Cancer in Gastric Intestinal Metaplasia (GIM) Patient: a Recommendation for Thai Population Unknown status NCT01490541
33 Nutritional Safety and Metabolic Benefits of Oncometabolic Surgery for Obese Gastric Cancer Patients Unknown status NCT03067012 Not Applicable
34 Improving Diabetes by Reconstruction Methods in Gastric Cancer Patients With Diabetes Mellitus Unknown status NCT01375738 Not Applicable
35 Standardization of D2 Lymphadenectomy and Surgical Quality Control: KLASS-02-QC Unknown status NCT01283893
36 Clinical Study for the Impact of Bio-absorbable Felt (NEOVEIL®) With Fibrin Sealant on Removal of Drainage Tube After Minimally Invasive Gastrectomy for Gastric Cancer Unknown status NCT01742806 Not Applicable
37 Comparison of Proton Pump Inhibitor and H2 Receptor Blocker on Prevention of Bleeding From Iatrogenic Ulcer After Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Randomized Controlled Trial Unknown status NCT01179724 Not Applicable high dose proton pump inhibitor;H2RB
38 PCLE for the Diagnosis of Gastric Intestinal Metaplasia, Intraepithelial Neoplasia, and Carcinoma Unknown status NCT02515721 Not Applicable
39 The Learning Curve of Probe-based Confocal Laser Endomicroscopy (pCLE) Images Interpretation in Gastric Intestinal Metaplasia (GIM) Unknown status NCT01491724
40 OLGA Stage is More Appropriate in Predicting Early Gastric Cancer Completed NCT02562976
41 Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients Completed NCT01643811
42 Endoscopic Submucosal Dissection Versus Gastrectomy Completed NCT02216110
43 Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer Completed NCT01544413 Not Applicable
44 Usefulness of Probe-based Confocal Laser Endo-microscopy in Delineation of Margin of Early Gastric Cancer for Endoscopic Submucosal Dissection Completed NCT02189226 Not Applicable
45 Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy Completed NCT00851305 Not Applicable
46 Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer Completed NCT01943253 Not Applicable
47 Necessity Assessment of ME-NBI Targeted Biopsy Compared With EFB Completed NCT02738294 Not Applicable
48 Enhanced Magnifying Endoscopy for Diagnosis of Early Gastric Cancer Completed NCT01617876
49 Endoscopic Submucosal Dissection (ESD)- Master Slave Robotic System - Human Study Completed NCT01394861 Early Phase 1
50 Monitored Anesthesia Care With Propofol Plus Remifentanil During Endoscopic Submucosal Dissection: Evaluation of Bispectral Index Monitoring Completed NCT01921283 Not Applicable no- BIS sensor attachment

Search NIH Clinical Center for Microinvasive Gastric Cancer

Sources

Genetic Tests for Microinvasive Gastric Cancer

About this section
Sources

Anatomical Context for Microinvasive Gastric Cancer

About this section

MalaCards organs/tissues related to Microinvasive Gastric Cancer:

42
Lymph Node, Liver, Bone, Testes, Bone Marrow, Colon, Neutrophil
Sources

Publications for Microinvasive Gastric Cancer

About this section

Articles related to Microinvasive Gastric Cancer:

(show top 50) (show all 1892)
# Title Authors Year
1
New metastatic lymph node classification for early gastric cancer should differ from those for advanced gastric adenocarcinoma: Results based on the SEER database. ( 30705892 )
2019
2
A Diagnostically Challenging Case of Autoimmune Pancreatitis Due to Contamination of the Pathological Specimen with Early Gastric Cancer. ( 30626846 )
2019
3
miR-106b Promotes Metastasis of Early Gastric Cancer by Targeting ALEX1 in Vitro and in Vivo. ( 30907988 )
2019
4
The Use of CD44 Variant 9 and Ki-67 Combination Can Predicts Prognosis Better Than Their Single Use in Early Gastric Cancer. ( 30913874 )
2019
5
Comparable rates of lymph node metastasis and survival between the diffuse-type and intestinal-type early gastric cancer patients: a large population-based study. ( 30885598 )
2019
6
Utility of linked color imaging for endoscopic diagnosis of early gastric cancer. ( 30886507 )
2019
7
Learning Effect of Diagnosing Depth of Invasion Using Non-Extension Sign in Early Gastric Cancer. ( 30889600 )
2019
8
Artificial intelligence for early gastric cancer: early promise and the path ahead. ( 30902205 )
2019
9
Epstein-Barr virus status is a promising biomarker for endoscopic resection in early gastric cancer: proposal of a novel therapeutic strategy. ( 30826866 )
2019
10
Stratification of Postsurgical Computed Tomography Surveillance Based on the Extragastric Recurrence of Early Gastric Cancer. ( 30829697 )
2019
11
Does Helicobacter pylori Eradication Reduce the Incidence of Metachronous Gastric Cancer After Curative Endoscopic Resection of Early Gastric Cancer: A Systematic Review and Meta-Analysis. ( 30829904 )
2019
12
Early gastric cancer with ball valve syndrome treated by endoscopic submucosal dissection. ( 30838513 )
2019
13
Clinical utility of miniprobe endoscopic ultrasonography for prediction of invasion depth of early gastric cancer: A meta-analysis of diagnostic test from PRISMA guideline: Erratum. ( 30855512 )
2019
14
Sentinel Lymph Node Sampling for Early Gastric Cancer-Preliminary Results of A North American Prospective Study. ( 30859424 )
2019
15
A deep neural network improves endoscopic detection of early gastric cancer without blind spots. ( 30861533 )
2019
16
Laparoscopic gastrectomy for early gastric cancer and the risk factors of lymph node metastasis. ( 30777995 )
2019
17
Comparison of endoscopic submucosal dissection with surgical gastrectomy for early gastric cancer: An updated meta-analysis. ( 30788042 )
2019
18
Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysis. ( 30805782 )
2019
19
Clinical utility of miniprobe endoscopic ultrasonography for prediction of invasion depth of early gastric cancer: A meta-analysis of diagnostic test from PRISMA guideline. ( 30732202 )
2019
20
Clinicopathologic characteristics of early gastric cancer according to specific intragastric location. ( 30736729 )
2019
21
Endoscopic management of patients with early gastric cancers before and after endoscopic resection: a review. ( 30756514 )
2019
22
Metachronous gastric cancer risk after endoscopic resection of early gastric cancer and H. pylori status. ( 30770974 )
2019
23
A case of early gastric cancer in a patient with splenic vein angioplany. ( 30668718 )
2019
24
Strategy for Curative Endoscopic Resection of Undifferentiated-Type Early Gastric Cancer. ( 30674183 )
2019
25
Impact of examining additional deeper sections on the pathological diagnosis of endoscopically resected early gastric cancer. ( 30681202 )
2019
26
Possibility of limited gastrectomy for early gastric cancer located in the upper third of the stomach, based on the distribution of sentinel node basins. ( 30684050 )
2019
27
Long-term outcomes of endoscopic submucosal dissection versus surgery in early gastric cancer: a systematic review and meta-analysis. ( 30694909 )
2019
28
Toward More Accurate Understanding of Lymph Node Metastasis Risk in Early Gastric Cancer. ( 30698606 )
2019
29
Association of the Collagen Signature in the Tumor Microenvironment With Lymph Node Metastasis in Early Gastric Cancer. ( 30698615 )
2019
30
A suitable marking method to achieve lateral margin negative in endoscopic submucosal dissection for undifferentiated-type early gastric cancer. ( 30705962 )
2019
31
SURVIVAL AND PERIOPERATIVE MORBIDITY OF TOTALLY LAPAROSCOPIC VERSUS OPEN GASTRECTOMY FOR EARLY GASTRIC CANCER: ANALYSIS FROM A SINGLE LATIN AMERICAN CENTRE. ( 30624522 )
2019
32
Natural history of early gastric cancer: series of 21 cases. ( 30648138 )
2019
33
Pitfalls in the Interpretation of Publications about Endoscopic Submucosal Dissection of Early Gastric Cancer with Undifferentiated-Type Histology. ( 30650945 )
2019
34
FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer. ( 30603905 )
2019
35
Long-term clinical outcomes of endoscopic vs. surgical resection for early gastric cancer with undifferentiated histology. ( 30604260 )
2019
36
Feasibility of Endoscopic Resection in Early Gastric Cancer with Lymphovascular Invasion. ( 30565046 )
2019
37
The incidence of lymph node metastasis in submucosal early gastric cancer according to the expanded criteria: a systematic review. ( 30298447 )
2019
38
A method of detecting two tumor markers (p-hydroxybenzoic acid and p-cresol) in human urine using a porous magnetic <beta>-cyclodextrine polymer as solid phase extractant, an alternative for early gastric cancer diagnosis. ( 30262042 )
2019
39
Risk factors for lymph node metastasis in non-sentinel node basins in early gastric cancer: sentinel node concept. ( 29799060 )
2019
40
Safety and feasibility of laparoscopic gastrectomy accompanied by D1+ lymph node dissection for early gastric cancer in elderly patients. ( 29577648 )
2019
41
Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen. ( 29977284 )
2018
42
Endoscopic submucosal dissection of early gastric cancer via inverted overtube in a patient with situs inversus totalis: a case report. ( 29756022 )
2018
43
Long-term outcomes after noncurative endoscopic resection ofA early gastric cancer: the optimal time for additional endoscopicA treatment. ( 29031882 )
2018
44
The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: aA systematic review of the literature and meta-analysis. ( 28966062 )
2018
45
The value of diagnostic endoscopic submucosal dissection for patients with clinical submucosal invasive early gastric cancer. ( 28484889 )
2018
46
Clinical Utility of a STAT3-Regulated miRNA-200 Family Signature with Prognostic Potential in Early Gastric Cancer. ( 29330205 )
2018
47
Serial intermediate-term quality of life comparison after endoscopic submucosal dissection versus surgery in early gastric cancer patients. ( 29067581 )
2018
48
Long-term outcomes of patients with early gastric cancer found to have lesions for which endoscopic treatment is not indicated on histopathological evaluation after endoscopic submucosal dissection. ( 28840337 )
2018
49
Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab. ( 29978335 )
2018
50
Early Gastric Cancer with Purely Enteroblastic Differentiation and No Conventional Adenocarcinoma Component. ( 30228922 )
2018
Sources

Variations for Microinvasive Gastric Cancer

About this section
Sources

Expression for Microinvasive Gastric Cancer

About this section
Search GEO for disease gene expression data for Microinvasive Gastric Cancer.
Sources

Pathways for Microinvasive Gastric Cancer

About this section

Pathways related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Pathways in cancer 38
12.18 CDH1 MLH1 TP53 VEGFC
2
Gastric cancer 38
Show member pathways
 11.59 CDH1 CDX2 MLH1 TP53
3
Colorectal Cancer Metastasis 65
11.35 CDH1 MLH1 TP53
Sources

GO Terms for Microinvasive Gastric Cancer

About this section

Biological processes related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium ion transport GO:0006814 9.5 ATP12A ATP4A SCN10A
2 ATP hydrolysis coupled proton transport GO:0015991 9.4 ATP12A ATP4A
3 resolution of meiotic recombination intermediates GO:0000712 9.37 EME2 MLH1
4 cellular sodium ion homeostasis GO:0006883 9.26 ATP12A ATP4A
5 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.16 ATP12A ATP4A
6 cellular potassium ion homeostasis GO:0030007 8.96 ATP12A ATP4A
7 sodium ion export across plasma membrane GO:0036376 8.62 ATP12A ATP4A

Molecular functions related to Microinvasive Gastric Cancer according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 sodium:potassium-exchanging ATPase activity GO:0005391 8.96 ATP12A ATP4A
2 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP12A ATP4A
Sources

Sources for Microinvasive Gastric Cancer

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....